Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 5
1987 5
1988 2
1989 6
1990 3
1991 2
1992 6
1993 15
1994 2
1995 2
1996 2
1997 3
1998 5
1999 9
2000 9
2001 12
2002 20
2003 13
2004 19
2005 19
2006 26
2007 38
2008 22
2009 15
2010 16
2011 30
2012 29
2013 18
2014 21
2015 23
2016 23
2017 24
2018 26
2019 38
2020 30
2021 43
2022 25
2023 16
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

568 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary fibrosis and type-17 immunity.
Senoo S, Higo H, Taniguchi A, Kiura K, Maeda Y, Miyahara N. Senoo S, et al. Among authors: kiura k. Respir Investig. 2023 Sep;61(5):553-562. doi: 10.1016/j.resinv.2023.05.005. Epub 2023 Jun 23. Respir Investig. 2023. PMID: 37356133 Review.
Managing Lung Cancer with Comorbid Interstitial Pneumonia.
Ichihara E, Miyahara N, Maeda Y, Kiura K. Ichihara E, et al. Among authors: kiura k. Intern Med. 2020 Jan 15;59(2):163-167. doi: 10.2169/internalmedicine.3481-19. Epub 2019 Sep 18. Intern Med. 2020. PMID: 31534086 Free PMC article. Review.
Nivolumab for the treatment of unresectable pleural mesothelioma.
Hotta K, Fujimoto N, Kozuki T, Aoe K, Kiura K. Hotta K, et al. Among authors: kiura k. Expert Opin Biol Ther. 2020 Feb;20(2):109-114. doi: 10.1080/14712598.2020.1703945. Epub 2019 Dec 16. Expert Opin Biol Ther. 2020. PMID: 31825692 Review.
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration.
Morinaga T, Inozume T, Kawazu M, Ueda Y, Sax N, Yamashita K, Kawashima S, Nagasaki J, Ueno T, Lin J, Ohara Y, Kuwata T, Yukami H, Kawazoe A, Shitara K, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Kawahara Y, Nakamura Y, Kiniwa Y, Morita A, Ichihara E, Kiura K, Enokida T, Tahara M, Hasegawa Y, Mano H, Suzuki Y, Nishikawa H, Togashi Y. Morinaga T, et al. Among authors: kiura k. Cancer Res Commun. 2022 Jul 28;2(7):739-753. doi: 10.1158/2767-9764.CRC-22-0050. eCollection 2022 Jul. Cancer Res Commun. 2022. PMID: 36923281 Free PMC article.
Chemotherapy for lung cancer: still alive!
Kiura K. Kiura K. Jpn J Clin Oncol. 2015 Jul;45(7):609-10. doi: 10.1093/jjco/hyv074. Epub 2015 May 19. Jpn J Clin Oncol. 2015. PMID: 25989990 No abstract available.
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer.
Nishii K, Ohashi K, Tomida S, Nakasuka T, Hirabae A, Okawa S, Nishimura J, Higo H, Watanabe H, Kano H, Ando C, Makimoto G, Ninomiya K, Kato Y, Kubo T, Ichihara E, Hotta K, Tabata M, Toyooka S, Udono H, Maeda Y, Kiura K. Nishii K, et al. Among authors: kiura k. Cancer Immunol Res. 2022 Sep 1;10(9):1111-1126. doi: 10.1158/2326-6066.CIR-21-0751. Cancer Immunol Res. 2022. PMID: 35802887 Free article.
Molecular oncology of lung cancer.
Toyooka S, Mitsudomi T, Soh J, Aokage K, Yamane M, Oto T, Kiura K, Miyoshi S. Toyooka S, et al. Among authors: kiura k. Gen Thorac Cardiovasc Surg. 2011 Aug;59(8):527-37. doi: 10.1007/s11748-010-0743-3. Epub 2011 Aug 18. Gen Thorac Cardiovasc Surg. 2011. PMID: 21850578 Review.
568 results